[go: up one dir, main page]

AU5114000A - P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain - Google Patents

P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain

Info

Publication number
AU5114000A
AU5114000A AU51140/00A AU5114000A AU5114000A AU 5114000 A AU5114000 A AU 5114000A AU 51140/00 A AU51140/00 A AU 51140/00A AU 5114000 A AU5114000 A AU 5114000A AU 5114000 A AU5114000 A AU 5114000A
Authority
AU
Australia
Prior art keywords
cytokinedomain
therapeutic agent
dimensional structure
tumor therapeutic
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51140/00A
Inventor
Yeong Joon Jo
Sunghoon Kim
Young Soo Kim
Young-Gyu Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imagene Co Ltd
Original Assignee
Imagene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagene Co Ltd filed Critical Imagene Co Ltd
Publication of AU5114000A publication Critical patent/AU5114000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU51140/00A 2000-06-14 2000-06-14 P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain Abandoned AU5114000A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2000/000630 WO2001095927A1 (en) 2000-06-14 2000-06-14 P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain

Publications (1)

Publication Number Publication Date
AU5114000A true AU5114000A (en) 2001-12-24

Family

ID=19198230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51140/00A Abandoned AU5114000A (en) 2000-06-14 2000-06-14 P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain

Country Status (3)

Country Link
KR (1) KR100425018B1 (en)
AU (1) AU5114000A (en)
WO (1) WO2001095927A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
KR100515016B1 (en) 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 Pharmaceutical composition for wound treatment containing p43 as an effective component
AU2003206144A1 (en) * 2003-01-15 2004-08-10 Imagene Co., Ltd. Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
AU2006211730A1 (en) * 2005-02-01 2006-08-10 Imagene Co., Ltd. Method for stimulation collagen synthesis and/or KGF expression
WO2008007818A1 (en) * 2006-07-13 2008-01-17 Seoul National University Industry Foundation Novel use of aimp1 for controlling glucose level
CN101190329B (en) * 2006-11-29 2013-03-06 信谊药厂 Medicinal composition for regrouping human P43 protein and its application in medication
EP1930342B1 (en) * 2006-12-04 2012-01-25 Institut Pasteur OB-fold used as scaffold for engineering new specific binders
CN101225371B (en) * 2007-01-18 2012-04-18 信谊药厂 Preparation process of recombinant human p43 protein
AU2008211884A1 (en) * 2007-02-01 2008-08-07 Imagene Co., Ltd. Novel polypeptide having anti-tumor activity
KR101067817B1 (en) * 2008-10-10 2011-09-27 서울대학교산학협력단 A composition for diagnosing arthritis, comprising an antibody against an AIMP1 polypeptide
CN102109527B (en) * 2009-12-28 2015-04-22 上海信谊药厂有限公司 Method for measuring biological activity of recombinant human p43 protein
KR101399077B1 (en) 2010-06-24 2014-05-27 (주)지노믹트리 Recombinant Vector Containing a Gene Encoding Adenylate Cyclase Activating Polypeptide 1 (pituitary) for Inhibiting Cervical Cancer Cell-Growth and Pharmaceutical Composition for Cervical Cancer Treatment Using the Same
CA2804424C (en) 2010-07-12 2021-03-30 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
CN104334196B (en) 2012-02-16 2018-04-10 Atyr 医药公司 For treating the Histidyl-tRNA-synthetase of autoimmune disease and inflammatory disease
JP6397479B2 (en) 2013-03-15 2018-09-26 エータイアー ファーマ， インコーポレイテッド Histidyl-tRNA synthetase Fc conjugate
KR101410904B1 (en) 2013-05-09 2014-07-02 재단법인 의약바이오컨버젼스연구단 Method for screening of anti-cancer agent and inflammatory disease agent
CN107735096A (en) * 2015-05-07 2018-02-23 贝勒医学院 Dendritic cell vaccination therapy
CN110536694A (en) 2017-04-20 2019-12-03 Atyr 医药公司 Compositions and methods for treating pulmonary inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
WO2000029620A1 (en) * 1998-11-13 2000-05-25 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain

Also Published As

Publication number Publication date
KR100425018B1 (en) 2004-03-27
KR20010112108A (en) 2001-12-20
WO2001095927A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU5114000A (en) P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2001280455A1 (en) Therapeutic device and system
AU2002211391A1 (en) Enhanced virtual navigation and examination
AU2001253479A1 (en) Targeted therapeutic agent release devices and methods of making and using the same
AU2002245629A1 (en) Stabilized therapeutic and imaging agents
AU2002361597A1 (en) Combination spa and entertainment system
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU2002218095A1 (en) Hidden air jet and air massage system
AU2002252976A1 (en) Hydrazones and their therapeutic use
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU8037900A (en) Modular processing devices and methods of use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002219249A1 (en) Enteric-coated drug formulations and their manufacture
AU3501700A (en) Human endokine alpha and methods of use
TW465320U (en) Structure of computer armrest
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU2001275696A1 (en) Therapeutic agent
GB0018887D0 (en) Compound and their therapeutic use
AU6106801A (en) Trans-clitoral administration of therapy
AU2002231267A1 (en) Analogues of thiocoraline and BE-22179

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase